Skip to main content
Erschienen in: Diabetologia 3/2012

01.03.2012 | Short Communication

Novel versus traditional risk markers for diabetic retinopathy

verfasst von: M. B. Sasongko, T. Y. Wong, T. T. Nguyen, J. E. Shaw, A. J. Jenkins, J. J. Wang

Erschienen in: Diabetologia | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

To explore the relative contribution of novel and traditional risk markers for diabetic retinopathy (DR).

Methods

A clinic-based study of 224 diabetic patients (85 type 1, 139 type 2) from a diabetes clinic was performed. DR was graded from fundus photographs according to the Airlie House Classification system and classified as absent or present (at least ETDRS level 14). Novel risk markers assessed included serum apolipoprotein (Apo) AI and B, skin microvascular responses to acetylcholine (endothelium-dependent) and sodium nitroprusside (endothelium-independent) iontophoresis, flicker-light-induced retinal vasodilation and retinal vascular tortuosity. Relative contribution was determined by semi-partial correlation coefficient generated from a logistic regression model containing all traditional and novel risk markers simultaneously.

Results

There were 144 (64.3%) participants with DR. Of the novel markers, ApoAI, flicker-light-induced vasodilation and retinal arteriolar tortuosity were significantly associated with DR, independently of traditional measures (all p < 0.03). Diabetes duration contributed most (51%) to the risk of DR, followed by ApoAI (16%), systolic blood pressure (13%), retinal arteriolar tortuosity (8%) and flicker-light-induced venular and arteriolar dilation (3% and 0.5%, respectively).

Conclusions/interpretation

ApoAI and retinal arteriolar tortuosity made considerable contributions to DR risk, independently of traditional risk markers. Findings from this study suggest that serum ApoAI and retinal arteriolar tortuosity may be novel and independent risk markers of DR.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Hirsch IB, Brownlee M (2010) Beyond hemoglobin A1c: need for additional markers of risk for diabetic microvascular complications. JAMA 303:2291–2292PubMedCrossRef Hirsch IB, Brownlee M (2010) Beyond hemoglobin A1c: need for additional markers of risk for diabetic microvascular complications. JAMA 303:2291–2292PubMedCrossRef
3.
Zurück zum Zitat Van Hecke MV, Dekker JM, Nijpels G et al (2005) Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 48:1300–1306PubMedCrossRef Van Hecke MV, Dekker JM, Nijpels G et al (2005) Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 48:1300–1306PubMedCrossRef
4.
Zurück zum Zitat Sasongko MB, Wong TY, Nguyen TT et al (2011) Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care 34:474–479PubMedCrossRef Sasongko MB, Wong TY, Nguyen TT et al (2011) Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care 34:474–479PubMedCrossRef
5.
Zurück zum Zitat Nguyen TT, Shaw JE, Robinson C et al (2011) Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow. Diabetes Care 34:1389–1393PubMedCrossRef Nguyen TT, Shaw JE, Robinson C et al (2011) Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow. Diabetes Care 34:1389–1393PubMedCrossRef
6.
Zurück zum Zitat Nguyen TT, Kawasaki R, Wang JJ et al (2009) Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32:2075–2080PubMedCrossRef Nguyen TT, Kawasaki R, Wang JJ et al (2009) Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32:2075–2080PubMedCrossRef
7.
Zurück zum Zitat Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ (2011) Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 54:2409–2416PubMedCrossRef Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ (2011) Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 54:2409–2416PubMedCrossRef
8.
Zurück zum Zitat (1981) Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Investig Ophthalmol Vis Sci 21:1–226 (1981) Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Investig Ophthalmol Vis Sci 21:1–226
9.
Zurück zum Zitat Turner J, Belch JJ, Khan F (2008) Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 18:109–116PubMedCrossRef Turner J, Belch JJ, Khan F (2008) Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 18:109–116PubMedCrossRef
Metadaten
Titel
Novel versus traditional risk markers for diabetic retinopathy
verfasst von
M. B. Sasongko
T. Y. Wong
T. T. Nguyen
J. E. Shaw
A. J. Jenkins
J. J. Wang
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 3/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2424-x

Weitere Artikel der Ausgabe 3/2012

Diabetologia 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.